ArticleJournal of experimental & clinical cancer research : CR2024

Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells.

Angela Filograna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.